Diverse coactivator recruitment through differential PPARγ nuclear receptor agonism

Fernando Lizcano1, Diana Vargas

  • 1Biomedical Research Center, Universidad de La Sabana, Chía, Colombia.

Insights

Telmisartan partially modulates PPARγ activity differently than rosiglitazone, with cofactors SRC1 and GRIP1 mediating these effects. This finding offers insights for developing new metabolic disease therapies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Endocrinology

Background:

  • Peroxisome proliferator-activated receptor gamma (PPARγ) is a nuclear receptor regulating lipid and carbohydrate metabolism, showing protective effects in type 2 diabetes.
  • Therapeutic use of PPARγ is limited by secondary effects of its ligands.
  • Ligand-induced conformational changes in PPARγ dictate downstream effects through cofactor binding.

Purpose of the Study:

  • To investigate the differential effects of various ligands on PPARγ cofactor binding.
  • To compare the effects of rosiglitazone (type 2 diabetes) and telmisartan (arterial hypertension) on PPARγ activity.
  • To identify cofactors mediating ligand-specific PPARγ modulation.

Main Methods:

  • Functional, phenotypic, and molecular studies were performed on pre-adipocyte 3T3-L1 cells.
  • Functional studies were conducted in U2OS cells.
  • Transient transfection assays were used to evaluate cofactor family influence on PPARγ.

Main Results:

  • Telmisartan demonstrated a partial modulating effect on PPARγ activity compared to rosiglitazone.
  • Cofactors Steroid Receptor Coactivator 1 (SRC1) and Glucocorticoid Receptor Interacting Protein 1 (GRIP1) were identified as mediators of telmisartan and rosiglitazone activity.
  • These cofactors partially explain the differential effects observed between the two ligands.

Conclusions:

  • Telmisartan exhibits partial agonism at PPARγ, distinct from the effects of rosiglitazone.
  • SRC1 and GRIP1 play a crucial role in mediating the differential activities of PPARγ ligands.
  • Understanding cofactor modulation of PPARγ offers potential for developing targeted therapies for metabolic diseases.

Related Concept Videos

Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form dimers that...